Idexx Laboratories reported $79.24M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
Abbott USD 1.74B 23.39B Sep/2025
Accuray USD 100K 1000 Sep/2024
Align Technology USD 71.62M 133K Mar/2026
AngioDynamics USD 41.57M 127K Sep/2025
Dentsply International USD 200.3M 700K Mar/2026
Dexcom USD 385.9M 1.1M Mar/2026
Edwards Lifesciences USD 580.7M 0 Dec/2025
Fujifilm JPY 1.21B 33K Mar/2026
Globus Medical USD 135.06M 449K Dec/2025
Henry Schein USD 114.42M 1.35M Mar/2026
Idexx Laboratories USD 79.24M 611K Mar/2026
Inogen USD 23K 0 Dec/2023
Insulet USD 69.26M 1.08M Mar/2026
Integra LifeSciences USD 77.82M 69K Mar/2026
Intuitive Surgical USD 355.17M 674K Mar/2026
Neogen USD 217.67M 147K Dec/2025
Orthofix International USD 39.83M 315K Dec/2025
Phibro Animal Health USD 40.48M 0 Dec/2025
ResMed USD 190.83M 44.86M Mar/2026
Roche Holding CHF 795.62M 699.54K Dec/2025
Steris USD 98.07M 72K Mar/2026
Tandem Diabetes Care USD 68.29M 518K Dec/2025
Teleflex USD 44.26M 70K Mar/2026
Thermo Fisher Scientific USD 371.62M 4.09M Mar/2026
Zoetis USD 420.35M 4.58M Mar/2026